key: cord-0803267-ooyynuxa
authors: Komorowski, Matthieu; Aberegg, Scott K.
title: Using applied lung physiology to understand COVID-19 patterns
date: 2020-05-27
journal: Br J Anaesth
DOI: 10.1016/j.bja.2020.05.019
sha: 29e361a5ae7b646cda23f5124a3af7c439c53b3f
doc_id: 803267
cord_uid: ooyynuxa

nan

Identifying patterns in observations has led to some of the most important scientific discoveries, such as the workings of the solar system (Copernicus), natural selection (Darwin), the periodic table (Mendeleev) and plate tectonics (Wegener). Drawing parallels and building models to explain observations is an inherent mode of brain functioning to comprehend the world 1 . As stated by Charbonneau: "Patterns give rise to scientific discovery; a break from an expected pattern or a newly recognized pattern demands to be explored, clarified, and understood. Connecting seemingly unrelated patterns can also lead to scientific discoveries…When scientists begin to 2 see a series of patterns that all support the same conclusion, they can form a hypothesis that they can test by collecting more data and looking for more patterns. Sometimes, the comparison may appear far-fetched but nonetheless valuable into highlighting disease mechanisms (e.g. muscle disuse in astronauts in space and ICU-acquired weakness 2 ). Patterns can not only lead to discovery, but also to prediction and action. Improving water sanitation in 19 th century England had clear effects on cholera epidemics, and understanding the major blood types proved crucial for transfusions during World War I.

Since December 2019, COVID-19 has rapidly swept across the world. Efforts came from all corners to try to improve our understanding and management of this highly challenging disease, and unsurprisingly, a vast number of hypotheses and suggestions have arisen, based on the patterns of diseases, identifying phenotypes, or drawing parallels with occasionally seemingly disconnected clinical pictures. To list just a few examples, it has been suggested that COVID-19 had two major lung 3 phenotypes 3 4 , that it was related to high altitude pulmonary oedema 5 , that it was linked with vitamin C 6 or D 7 , UV index 8 , melatonin 9 , or nicotine 10 . Some of these hypotheses have generated heated debates among scientists. Gattinoni describes explicitly the process of seeking patterns in his COVID-19 patients: "These severely hypoxaemic patients despite sharing a single aetiology (SARS-CoV-2) may present quite differently from one another: normally breathing ("silent" hypoxaemia) or remarkably dyspnoeic; quite responsive to nitric oxide or not; deeply hypocapnic or normo/hypercapnic; and either responsive to prone position or not. Therefore, the same disease actually presents itself with impressive non-uniformity" 3 . Similar remarks can be found online, for example from an emergency physician in New York: "You get used to seeing certain patterns, and the patterns I was seeing did not make sense." 11 patients moving away from the strict ARDSNet protocol have been proposed 3 4 .

In this issue of the British Journal of Anaesthesia, Ottestad and colleagues 12 compare COVID-19 patient to high altitude exposure. The authors argue that the acute exposure to altitude in otherwise healthy subjects leads to profound hypoxaemia with relatively little respiratory distress (so-called "silent hypoxia" or "happy hypoxia"), as well as a decrease in PaCO 2 from compensatory hyperventilation, both phenomenon also commonly observed in COVID-19 patients.

By exposing healthy subjects to acute hypobaric hypoxia, the authors elegantly show how hypocapnia significantly shifts the oxygen-haemoglobin dissociation curve and improves blood oxygen saturation. The approach taken by Ottestad and colleagues 4 of examining the disease behaviour through the lens of applied lung physiology is very insightful and can be taken one notch further. A deep understanding of the clinical picture of COVID-19 patients can be gained by analysing the science behind respiratory failure, and what drives the minute ventilation [13] [14] [15] .

In a steady state, the minute ventilation requirement of a patient is given by:

where is the minute ventilation (L/min), is the CO 2 production (L min -1 ), / s the ratio of physiological dead space to tidal volume, is the partial pressure of CO 2 in arterial blood and is a dimensional constant. This equation demonstrates that minute ventilation requirement is determined by only three factors:

CO 2 production, VD/VT and PaCO 2 .

It is important, yet underrecognized, that ventilation requirements (as elaborated by the equation above) and increased work of breathing are more potent drivers of subjective dyspnoea than hypoxaemia 14 . This underappreciation may result from the fact that in most clinically encountered diseases with severe hypoxaemia, there is concomitant increased work of breathing, leading to confounding of separate but related processes. The physical loads on the respiratory system responsible for high work of breathing in disease states fall into four main categories: 1) elastic loads impeding tidal excursions, e.g., from parenchymal or pleural disease, or skeletal deformities such as kyphoscoliosis; 2) resistive loads on airflow, e.g., from bronchospasm, or airway secretions or stenosis; 3) inertial mass of the respiratory system, e.g., an obese body habitus, the effects of which are exacerbated by 5 recumbency; and 4) minute ventilation requirements 14 16 . In obese patients, the inertial mass of the respiratory system is increased, and this effect is more pronounced when patients are supine and recumbent. When combined with high minute ventilation, the loads imposed by obesity may raise the work of breathing sufficiently to cause symptoms. While obesity appears to be an important risk factor for COVID-19 clinical illness as well as poor outcomes from it 19 , 6 whether this reflects the effects of obesity on the respiratory system or other factors remains to be determined. 19a To date, early in the course of illness neither prominent secretions nor bronchospasm have been reported in COVID-19 20 21 . Therefore, resistive loads on the respiratory system do not appear to be significant, at least early in the illness.

This leaves us with the highly contested issue According to this line of thinking, patients who begin with relatively normal compliance may, because of marked air hunger resulting in high transpulmonary pressure gradients and respiratory rates, self-inflict lung injury that reduces compliance as they continue to breathe spontaneously while generating high mechanical power 4 22 . In the context of the work of breathing scheme presented, their low compliance measured on the ventilator later in the course of disease is a consequence of lack of dyspnoea at the outset, which in other diseases would have precipitated intubation and mechanical ventilation with lung-protective mechanical ventilation much earlier. Proponents of P-SILI thereby recommend earlier intubation with lung-protective mechanical ventilation utilizing low tidal volumes to prevent ongoing self-induced lung injury 4 23 . Because of the protracted course of COVID-19 20 21 , it remains to be seen whether the benefits of such a strategy outweigh the known costs of prolonged sedation and paralysis required to achieve reduced mechanical power that would theoretically prevent P-SILI 24 25 . Important to consider with this strategy is the increased stress on finite ICU resources, namely ventilators, beds and staff 25 .

While it is possible that COVID-19 results in a unique subset or phenotype of ARDS, it is at least as likely that the COVID-19 pandemic has created an unusually large but otherwise usual population of patients with ARDS. The controversies surrounding phenotypes of ARDS in COVID-19 will take several years and reams of data to settle. Until then, it may be useful to utilize this opportunity to reflect on how the symptomatic presentation and course of COVID-19 differs from or conforms to our expectations, and what any discrepancies may teach us about the underlying physiological principles. Ottestad and colleagues 12 have pointed us in the right direction for reflection on the pathophysiology as additional data become available.

Hopefully, the insights we gain can inform us not only about COVID-19, but about respiratory failure in general. Meanwhile, we should be cautious in intervening on the basis of hypoxaemia and tachypnoea alone, without associated subjective dyspnoea and respiratory distress 15 .

MK wrote the first draft of the paper, which was subsequently extensively edited by MK and SKA. Both authors approved the final version of the manuscript.

The authors declare that they have no conflict of interest.

The Surprising Patterns of Health and Disease

Parallels between astronauts and terrestrial patients -Taking physiotherapy rehabilitation "To infinity and beyond

COVID-19 pneumonia: different respiratory treatments for different phenotypes?

Management of COVID-19 Respiratory Distress

Nifedipine and Phosphodiesterase Inhibitors: Rationale for Their Utilization as Adjunctive Countermeasures in the Treatment of Coronavirus Disease

A new clinical trial to test high-dose vitamin C in patients with COVID-19

Evidence that Vitamin D Supplementation Could Reduce Risk of Influenza and COVID-19 Infections and Deaths

On the global trends and spread of the COVID-19 outbreak: preliminary assessment of the potential relation between location-specific temperature and UV index

Melatonin: Roles in influenza, Covid-19, and other viral infections

A nicotinic hypothesis for Covid-19 with preventive and therapeutic implications

Do COVID-19 Vent Protocols Need a Second Look?

COVID-19 patients with respiratory failure: what can we learn from aviation medicine?

Can You Sustain What You Need?

Chapter 4 -Control of Breathing

Basing Respiratory Management of Coronavirus on Physiological Principles

Liberation From Mechanical Ventilation: A Decade of Progress

Respiratory Pathophysiology of Mechanically Ventilated Patients with COVID-19: A Cohort Study

Sustained maximum voluntary ventilation

High prevalence of obesity in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) requiring invasive mechanical ventilation

Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area

Features of 16,749 hospitalised UK patients with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol

The future of mechanical ventilation: lessons from the present and the past

Mechanical Ventilation to Minimize Progression of Lung Injury in Acute Respiratory Failure

A Word of Caution Regarding Patient Self-inflicted Lung Injury and Prophylactic Intubation

Treading Lightly in a Pandemic: #Zentensivist Reflections on COVID-19